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BACKGROUND: Diverting ileostomy is believed to mitigate the effects of anastomotic complications in
low anterior resections (LAR) for rectal cancer. However, there are no data about the effects of diverting
ileostomy on the outcomes of laparoscopic LAR. 
METHODS: We retrospectively reviewed the medical records of 77 consecutive rectal cancer patients
who had undergone laparoscopic LAR with (n = 23) or without (n = 54) diverting ileostomy. The patients’
data were recorded and supplemented on short-term follow-up visits and included standard demographics,
operative procedure, location of the cancer, and final pathologic diagnosis. We noted length of hospitali-
sation, complications, and time interval from ileostomy creation to closure. Morbidity and mortality were
also included. 
RESULTS: Surgical intervention requiring anastomotic leakage occurred in three patients who under-
went laparoscopic LAR without diverting ileostomy. The anastomosis level of patients who underwent
laparoscopic LAR with diverting ileostomy was significantly lower than that of patients who underwent
laparoscopic LAR without diverting ileostomy (p < 0.05). 
CONCLUSION: Anastomosis level and total mesorectal excision are the main factors for creation of
diverting ileostomy in laparoscopic LAR. Laparoscopic LAR without diverting ileostomy could be selec-
tively performed. Our study provides a basis for further prospective randomised studies on the role of
diverting ileostomy in LAR. [Asian J Surg 2011;34(2):63–68]
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Introduction
Low anterior resection (LAR) is defined as the removal of
the proximal portion of the rectum with re-anastomosis
of the colon to the extraperitonealised portion of the rec-
tum.1 The surgical approach to rectal carcinoma has pro-
gressed substantially in the last few decades because of
the application of laparoscopy to colorectal surgery.2–5
However, anastomotic leakage is still a serious problem
after sphincter-saving surgery for rectal cancer.6 Diverting
stomata are used to reduce leakage-related complications
after LAR, but the routine use of diverting stomata is con-
troversial because of reported morbidity associated with
their creation and closure.7,8
Many authors believe that patients treated with total
mesorectal excision (TME) and neoadjuvant chemoradio-
therapy (NCRT) require a diverting stoma after open
LAR.9–11 At the same time, there is a tendency for the cre-
ation of a diverting stoma in sphincter-saving laparo-
scopic rectal cancer surgery.9 No study has evaluated the
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role of diverting ileostomy in laparoscopic LAR. Therefore,
we evaluated the effects of diverting ileostomy on the out-
comes of laparoscopic LAR in rectal cancer patients. 
Patients and methods
We retrospectively reviewed the medical records of 77 
(40 male, 37 female) consecutive rectal cancer patients
who had undergone laparoscopic LAR (partial mesorectal
excision [PME] or TME) with or without diverting ileos-
tomy with curative intent by a single surgical team from
November 2003 to August 2009. The exclusion criteria for
performing laparoscopic LAR were (1) tumour-related
factors: tumours larger than 8 cm, obstructing tumour,
intestinal perforation, and tumours that invade adjacent
organs, and (2) patient-related factors: contraindications
for laparoscopic surgery such as severe cardiopulmonary
disease.
The patients’ data were recorded and supplemented
on short-term follow-up visits and included standard
demographics, the operative procedure, location of the
cancer, and the final pathologic diagnosis. We noted the
length of hospitalisation, complications, and time inter-
val from ileostomy creation to closure. Morbidity and
mortality were also included. The patients were followed
by the surgery and medical oncology outpatient clinics. 
Preoperative preparation
Physical examination, biochemical analysis, optical colo-
noscopy, biopsy of the tumoural lesion, and computed
tomography of the chest, abdomen, and pelvis were eval-
uated before surgery for every patient. In NCRT patients,
surgery was performed 6–8 weeks after completing NCRT.
A clear-fluid diet (90 mL of sodium phosphate soda per os)
was given to the patients for mechanical bowel preparation
on the day before the surgery. Antibiotic prophylaxis con-
sisted of metronidazole (500 mg) and was intravenously
administered at the time of anaesthesia induction. 
Surgical procedure
All patients underwent laparoscopic LAR by two surgeons
(TK and IH) under general anaesthesia. A standard tech-
nique was used as previously reported.12 Surgery was 
performed intra-corporeally and involved organ mobili-
sation, vessel ligation, colon and rectum transection, and
anastomosis. The patients were placed in the lithotomic
position (30º Trendelenburg and 15º right lateral tilt).
Four to five trocars were used for the procedure. Trocar
size was between 5 and 10 mm. Among these, one was
used as a camera port, one for retraction, and two as
working ports. Under laparoscopic guidance, routine
exploration was performed. The omentum and transverse
colon were placed beneath the diaphragm and over the
liver. The mesentery of the sigmoid colon was hung up by
a device that was placed inside via the port in the left
quadrant. The retroperitoneum was incised at the level of
the promontorium above the iliac bifurcation. The right
ureter and gonadal vessels were identified during medial
to lateral dissection. Toldt’s fascia was protected to pre-
serve these structures. Dissection was begun by ligation
of the inferior mesenteric artery close to its origin and the
inferior mesenteric vein at the inferior border of the pan-
creas. The mesorectum was then sharply dissected to the
pelvic floor posteriorly. With the help of posterior
anatomic dissection space, lateral dissection of the rec-
tum was performed. The sigmoid colon and the descend-
ing colon were freed from their lateral attachments before
anterior mesorectal excision. Special care was taken to
preserve the inferior mesenteric plexus and the hypogas-
tric plexus. The rectum was excised while completely
enveloped within the fascia propria recti in the TME
patients and was partially excised 5 cm below the peri-
toneal reflection in the PME patients. The resected speci-
men was retrieved within an extraction bag (Endocatch II,
US Surgical Corporation, Norwalk, CT, USA) through 
a Pfannenstiel incision. The anastomosis was performed
using a double-stapling technique with an endoscopic 
linear stapler and a circular stapler. Rectal washout was
performed during the anastomosis. The distance from the
anal verge to the anastomosis was measured with digital
rectal examination.
Closure of ileostomy
Before ileostomy closure, the distal anastomosis was
checked with a barium enema. Ileostomy closure was
approached via a circumstomal incision. A hand-sewn
anastomosis was performed with a single layer of inter-
rupted polyglycolic sutures. Side-to-side functional end-
to-end anastomosis was performed with two 6-cm linear
cutter staplers.
Histopathological evaluation
The specimens were sliced at approximately 3- to 5-mm
intervals after the mesorectal surface had been inked. The
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lymph nodes were submitted for microscopic examination.
Histopathological examination of the mesorectal fascia
was evaluated according to a standardised procedure
described by Quirke et al13 Recorded parameters included
the number of harvested lymph nodes and the longitudi-
nal and radial margins of the resected specimen. TNM
classification according to the American Joint Committee
on Cancer was used to determine the pathologic stage of
the tumour.
Statistics
All data are expressed as median (range). The Mann-
Whitney U test and the χ2 test (Fisher’s exact test) were
used for the continuous and the categorical variables,
respectively. Statistical Package for Social Sciences 12.0
(SPSS Inc., Chicago, IL, USA) was used to assess the sig-
nificance of differences between groups. A p value of less
than 0.05 was considered significant.
Results
The patients’ characteristics and histopathological 
results are given in Tables 1–3. There was no conversion
to open surgery during any procedure. Laparoscopic
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Table 1. Patients’ demographics and follow-up data
Ileostomy (+) Ileostomy (−)
(n= 23) (n= 54)
Age (yr)* 59 (40–78) 61 (40–91)
Sex (M/F) 15/8 25/29
Body mass index 28.4 (21–40) 24.7 (18.5–38.2)
(kg/m2)
Level of anastomosis 2 (1.5–3.5) 4.5 (2–7)†
(cm)*
No. of anastomotic – 3 (6%)
leakage
Stoma retraction 1 (4%) –
Need for permanent 1 (4%) 2 (4%)
stoma
Wound infection 2 (9%) 1 (2%)
Sexual dysfunction 1 (4%) –
Incisional hernia 1 (4%) –
Postoperative hospital 7 (5–16) 7 (6–19)
stay (d)*
Closure time of 4 (2–12) –
ileostomy (mo)*
*Data were expressed as median (range); †(p < 0.05). NCRT =
neoadjuvant chemoradiotherapy; ileostomy (+) = the patients with
ileostomy; ileostomy (−) = the patients without ileostomy. 
Table 2. Staging of the patients and mean number of harvested lymph nodes
TME (n= 23) TME (n= 17) PME (n= 37) 
Ileostomy (+) Ileostomy (−) Ileostomy (−)
Tumour stage
Stage I 10 4 12
Stage II 7 8 18
Stage III 6 4 4
Stage IV 0 1 3
Mean no. of harvested lymph nodes* 16 (3–31) 18 (12–28) 14 (10–28)
Evaluation of mesorectum
Complete 15 10 –
Incomplete 1 2 –
Near complete 7 5 –
*Data were expressed as median (range). TME = total mesorectal excision; PME = partial mesorectal excision; ileostomy (+) = patients with
ileostomy; ileostomy (−) = patients without ileostomy.
Table 3. Characteristics of the loop ileostomy patients
No. of patients
NCRT 5
Comorbidity 6
Positive hydropneumatic test 3
Longer stapler line with Z-form 3
Incomplete doughnuts 1
Tensile strength of anastomosis 1
Deep and narrow pelvis 4
NCRT = neoadjuvant chemoradiotherapy.
sphincter-saving TME was performed in 40 patients,
whereas 37 patients underwent laparoscopic PME. The
median distance of the anastomosis was 2 cm (1.5–3.5 cm)
from the anal verge for patients who underwent laparo-
scopic LAR with diverting ileostomy, whereas the median
distance was 4.5 cm (2–7 cm) for patients who underwent
laparoscopic LAR without diverting ileostomy. This value
was significantly different between the groups (p < 0.05).
Diverting ileostomy was created in 23 (30%) patients. The
patients who had diverting ileostomies also underwent
TME. No patients who underwent PME required a divert-
ing ileostomy. Comorbid factors, NCRT, deep and narrow
pelvis, positive hydropneumatic test result, longer stapler
line with Z-form, incomplete doughnuts, and tensile
strength of anastomosis were the common characteristics
in the diverting ileostomy patients. Six patients underwent
NCRT, and five of them received a diverting ileostomy.
Comorbid factors were uncontrolled diabetes mellitus in
two patients, severe kidney insufficiency in two patients,
and compensated chronic liver disease in two patients.
Uncontrolled diabetic patients also had peripheral neu-
ropathy, and one of them had a diabetic leg ulcer. Of these
patients, severe cardiac insufficiency developed in the one
whose stoma could not be closed. There were two end-stage
renal disease patients who had been receiving haemodial-
ysis treatment for 5 years. Both patients with hepatic insuf-
ficiency had hepatitis B infection and grade B (according
to the modified Child-Pugh classification) chronic liver
disease. The characteristics of the diverting ileostomy
patients are summarised in Table 3.
Our anastomotic leakage rate was 4% for all laparo-
scopic LAR and 6% for laparoscopic LAR without ileo-
stomy. No anastomotic leakage occurred in the patients
who underwent laparoscopic LAR with ileostomy. The
postoperative stay was 7 days (5–16 days) in patients with
a diverting ileostomy and 7 days (6–19 days) in patients
without diversion after laparoscopic LAR. There were no
statistically significant differences between the groups in
terms of anastomosis leakage, permanent stoma, wound
infection, sexual dysfunction, and incisional hernia rates
(p > 0.05). There were no statistically significant differ-
ences in terms of postoperative hospital stay, body mass
index, and number of harvested lymph nodes between
patients with or without diverting ileostomy (p > 0.05).
Prolonged postoperative hospital stay was associated with
wound infections and re-operations caused by anastomotic
leakage.
No patients had evidence of contrast extravasation
before stoma closure. Ileostomy closure was performed 
4 months (2–12 months) after the initial procedure. The
duration between ileostomy construction and closure was
changed according to the patients’ scheduling preferences,
waiting list, and need for adjuvant chemotherapy. 
The diverting stomata of only three patients were
unable to be closed. One patient did not want to undergo
re-operation, and one had severe cardiac disease that did
not allow for re-operation. A 75-year-old woman required
a permanent transverse colostomy after ileostomy closure
because of resistant faecal incontinence. 
Wound infection developed in three patients. Two of
these infections were related to the diverting ileostomy.
Sexual dysfunction (a male patient who had undergone
TME with a diverting ileostomy) was observed in one
patient. One patient required urgent surgery because of
retraction of the diverting ileostomy, and an incisional
hernia developed after ileostomy closure in another
patient. There was no perioperative or postoperative mor-
tality related to leakage or stoma complications.
Discussion
The survival of rectal cancer patients has been prolonged
with the utilisation of TME and NCRT. On the other
hand, these modalities are often associated with a high
frequency of anastomotic dehiscence.6–10 The overall
anastomotic leakage rate has been reported at 9.8–19.2%
in conventional LAR.14–17 A diverting stoma is often cre-
ated to minimise the impact of pelvic sepsis from an anas-
tomotic dehiscence following coloanal or colorectal
anastomosis.8,9,18 A temporary colostomy or ileostomy is
created for decompression of colorectal anastomosis as a
diverting stoma. No prospective studies have reported
that colostomy as a diverting stoma is better than ileo-
stomy or vice versa. Diverting colostomy causes a higher
rate of stoma complications such as infection and stoma
prolapse. However, ileostomy tended to cause more post-
closure surgical complications.19,20 We prefer the creation
of loop ileostomies in our clinical practice. 
As a minimally invasive procedure, laparoscopic LAR
is frequently preferred for the treatment of rectal cancer.
Many authors have agreed that laparoscopic LAR is a fea-
sible technique that can be performed in accordance with
the principles of surgical oncology.21–29 According to review
of the laparoscopic series, the mean stoma creation rate
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was approximately 50% (range, 0–65%) for LAR.21–26,28
Laparoscopy has been considered to be an additional risk
factor for leakage in rectal surgery.9 In our study, divert-
ing ileostomy was initially performed in 30% of all patients
and ultimately in 34%. Diverting ileostomies were also
created in three patients who had anastomotic leakage.
Our diverting stoma creation rate in laparoscopic LAR
was similar to that of the open series, and our anastomotic
leakage rate was 4% overall for laparoscopic LAR and 6%
for laparoscopic LAR without diverting ileostomy. 
Potential disadvantages of diverting stomata include
the need for another operation, longer hospital stay, and
ostomy-related complications such as prolapse, retrac-
tion, necrosis, stenosis, peristomal abscess, parastomal
hernia, and skin problems. Furthermore, ostomy construc-
tion and closure is associated with considerable morbidity
and increased costs.5,8,21 The morbidity can rise to 42%.
The patient’s quality of life significantly decreases because
of the stoma.30,31 Incisional hernia and stoma retraction
were the diverting ileostomy-related major complications
in our series. In many patients, the stoma closure time is
usually postponed. It could take 4 months depending on
factors such as hospital waiting lists, patient scheduling
preferences, and need for adjuvant chemotherapy. The
aesthetic appearance of laparoscopy may also be affected
by a diverting stoma. Although intended to be temporary,
a substantial proportion of these ostomies can never be
reversed.15,16 In our series, three of the diverting stomata
were not able to be reversed. 
It is difficult to select patients who will benefit from a
diverting stoma. The general indications for diversion are
low proximity of the anastomosis to the anal verge, high
tension of the anastomosis, leakage on hydro-pneumatic
tests, incomplete circular stapler doughnuts, NCRT, male
gender, obstruction, infection, peritoneal contamination,
intra-operative remarks, comorbidity, and surgeon’s expe-
rience.11,28 Harmful effects of NCRT on intestinal tissue
increase the morbidity of the surgical intervention. How-
ever, the diverting stoma rates in our open and laparo-
scopic LAR series were similar. Laparoscopy is not a factor
that forces us to create a diverting stoma in LAR. Diabetes,
end-stage renal disease, and chronic liver disease were the
comorbid factors of the patients who required ileostomy.
It is well known that these systemic chronic pathologies
cause malnutrition and impaired wound-healing processes.
The negative effects of these disorders on the intestines
may be noticed during surgical exploration by colorectal
surgeons and are important in determining whether the
diversion is needed. It is difficult to compare the results
of the studies because they were structured with hetero-
geneous groups of patients. Some series included anterior
resections, whereas others included patients who under-
went LAR.23,32 In our study, diverting ileostomy was not
performed depending on definitive criteria, but the risk
factors were similar to those in the literature data among
the diverting ileostomy patients. In our opinion, the sur-
geon’s discretion and experience may be the most impor-
tant factors in the decision of whether to add a diverting
stoma in laparoscopic LAR in high-risk patients. 
This was not a randomised prospective study. Planning
a randomised trial that compares diversion stoma versus
no diversion in LAR would be extremely difficult. It is
impossible to avoid a diverting ileostomy in high-risk
patients. Only one randomised study on this topic has been
published. Ulrich et al33 evaluated 34 patients who under-
went open LAR. They performed intra-operative randomi-
sation when they were satisfied with the safety of the
anastomosis depending on results of the air insufflation
test. They suggested that sphincter-saving LAR without
diverting ileostomy is risky and have declared that they
routinely create a diverting stoma in patients who undergo
LAR with TME in their clinical practice.33 Objectively,
diverting ileostomy reduces leakage-related complications
in LAR. However, according to the traditional approach,
some patients unnecessarily receive diverting stomata in
LAR. Of all the patients 66% of LAR and 35% of TME pa-
tients recovered without the need for diverting ileostomy. 
Anastomosis level and TME are the most frequent fac-
tors for creation of diverting ileostomy in laparoscopic
LAR. The low leakage rate of the anastomoses in our
laparoscopic LAR patients encourages us to selectively
create diverting ileostomies. This is the first study to eval-
uate the role of diverting ileostomy in laparoscopic LAR.
Our study provides a basis for further prospective ran-
domised studies on the role of diverting ileostomy in
laparoscopic LAR.
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